Navigation Links
Global NASH Therapeutics Market to Record 30% CAGR Through 2017, According to GlobalData Report Published at MarketPublishers.com
Date:11/4/2013

London, UK (PRWEB) November 04, 2013

Currently, the nonalcoholic steatohepatitis (NASH) market environment is very sparse on the back of high levels of unmet clinical and environmental needs for NASH, including approved therapies specific to NASH, physician education as well as patient awareness. The disease’s heterogeneous nature combined with its slow progression represents serious challenge in developing new drugs and designing innovative diagnostic tools.

In 2012, the world NASH market stood at around USD 233 million. It is likely to grow at a 30% CAGR to surpass the USD 862.9 billion mark by 2017. The market growth will be boosted considerably by the increasing prevalence of diabetes and obesity worldwide. The US is forecast to hold the lion’s share of the world NASH market, contributing around USD 827 million towards overall sales. It is likely to be followed by the top five European country markets (Germany, France, Spain, the UK and Italy).

In-demand research report “OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017” elaborated by GlobalData has been recently published by Market Publishers Ltd.

Report Details:

Title: OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017
Published: September, 2013
Pages: 128
Price:    US$ 5,995.00
http://marketpublishers.com/report/life_sciences/pharmaceuticals/opportunityanalyzer-nonalcoholic-steatohepatitis-nash-opportunity-analysis-n-forecasts-to-2017.html

The report provides in-depth unbiased insights into the global NASH therapeutics market. It presents a comprehensive profile of NASH, encompassing details about the disease its epidemiology, symptoms, pathology, diagnosis and treatment. The study covers the actual market performance as well as sheds light on the historical development of the market, offers extensive pipeline analysis including vital information on the important trends and developments. It uncovers estimates of annual therapy cost and treatment pattern for the 2012-2017 period, examines the key factors driving and restraining the industry growth, and also contains a strategic clinical and commercial benchmarking assessment of the pipeline and standard of care. Moreover, the market future outlook through 2019 is available in the report.

Report Scope:

  •     Insightful overview of the global NASH therapeutics market.
  •     Comprehensive disease profile including vital information on the disease epidemiology, symptoms, pathology, diagnosis and treatment.
  •     Review of the current treatment options.
  •     Thorough examination of unmet needs and analysis of the major opportunities in the NASH therapeutics market.
  •     Important data on NASH R&D strategies.
  •     Pipeline assessment and pipeline valuation analysis.
  •     Estimates of annual therapy cost and treatment usage for the 2012-2017 period.
  •     Market future outlook through 2019.

More insightful research reports by the publisher can be found at GlobalData page.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11298766.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Canada should play a role in addressing the global cancer epidemic
3. Global cardiology leaders meet in Dubai
4. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
5. International breast health global summit will focus on supportive care and quality of life
6. Scientists rewrite rulebook on breast cancer in landmark global study
7. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
8. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
9. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
10. New study identifies how information technology is used to solve global health challenges
11. New global report says US lags behind 130 other nations in preterm birth rate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Dental365 in Levittown opened just a few ... dentistry. Dental365 was established with the patient’s comfort and convenience in mind. ... high-quality, affordable dentistry while offering routine and walk-in emergency dental care 365 days a ...
(Date:5/4/2016)... ... May 05, 2016 , ... “Less than 15% of organizations nationwide can ... “As one of ten non-profit organizations to participate and complete the training, we are ... benefit is that for every $1 we invest in volunteer engagement, we can expect ...
(Date:5/4/2016)... ... May 04, 2016 , ... The manufacturer of the SOCKIT ... trainers to St. Jude Children’s Research Hospital to benefit families dealing with cancer ... designed to teach children how to kick a soccer ball correctly. The device ...
(Date:5/4/2016)... ... May 04, 2016 , ... NCPDP ... conference opened on Tuesday with Frank Luntz, sharing a dynamic, bi-partisan environmental scan ... a deep dive on NCPDP’s model solution to help stem the tide of ...
(Date:5/4/2016)... ... May 04, 2016 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... esteemed Quaker Ridge Golf Club in Scarsdale, New York on May 23, 2016 ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... JERUSALEM , May 4, 2016 ... University of Jerusalem announced today that it had ... BioTheryX, Inc. , developer of novel protein degradation ... the development and commercialization of drug candidates representing first-in-class ... the license were not disclosed. The novel ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
(Date:5/3/2016)... -- Research and Markets has announced the ... Market Outlook 2020" report to their offering. ... technology has improved significantly in past years due to ... coming years. Many cancer drugs have been developed by ... also expected to be developed with its help. They ...
Breaking Medicine Technology: